Learn more →
Back to Expert Scholars
research / researchcancer research global milestone

Elizabeth H. Blackburn

伊丽莎白·布莱克本

PhD

🏢University of California, San Francisco(加利福尼亚大学旧金山分校)🌐USA

Morris Herzstein Professor Emerita of Biology and Physiology, Department of Biochemistry and Biophysics生物化学与生物物理系莫里斯·赫茨坦生物学与生理学荣休教授

110
h-index
3
Key Papers
6
Awards
4
Key Contributions

👥Biography 个人简介

Elizabeth Blackburn shared the 2009 Nobel Prize in Physiology or Medicine with Carol Greider and Jack Szostak for the discovery of telomeres and the enzyme telomerase. Telomeres — the protective caps at chromosome ends — are critically relevant to cancer biology: telomere shortening triggers genomic instability that can initiate malignant transformation, while telomerase reactivation in ~90% of human cancers enables unlimited replicative capacity, one of the core hallmarks of cancer. Blackburn's work established telomere maintenance as both a driver of carcinogenesis and a therapeutic target. She also served on the President's Council on Bioethics and has been a prominent advocate for research integrity and women in science.

Share:

🧪Research Fields 研究领域

Telomeres and Cancer端粒与癌症
Telomerase Discovery端粒酶发现
Cellular Aging细胞衰老
Genomic Stability基因组稳定性
Cancer Biology癌症生物学

🎓Key Contributions 主要贡献

Telomere Structure and Function

Discovered the repetitive DNA sequence structure of telomeres and demonstrated their essential role in protecting chromosome ends from degradation and end-joining, explaining how chromosomal integrity is maintained.

Telomerase Discovery

Co-discovered telomerase with Carol Greider, identifying the ribonucleoprotein enzyme that synthesizes telomere repeats and enables cells to maintain telomere length — explaining how cancer cells achieve immortality.

Telomeres in Cancer and Aging

Established the mechanistic connections between telomere dysfunction, genomic instability, cancer initiation, and cellular senescence, providing a unified framework for aging and cancer biology.

Telomerase as Cancer Therapeutic Target

Demonstrated that telomerase is reactivated in ~90% of human cancers while absent in most normal somatic cells, establishing it as a near-universal cancer target for diagnostic and therapeutic development.

Representative Works 代表性著作

[1]

A Tandemly Repeated Sequence at the Termini of the Extrachromosomal Ribosomal RNA Genes in Tetrahymena

Journal of Molecular Biology (1978)

Original discovery of the telomeric repeat sequence structure, laying the foundation for the Nobel Prize-winning body of work on telomeres.

[2]

Identification of a Specific Telomere Terminal Transferase Activity in Tetrahymena Extracts

Cell (1985)

Co-discovery of telomerase with Carol Greider, identifying the enzyme that maintains telomere length and explaining cellular immortality in cancer.

[3]

Telomeres and Telomerase: The Path from Maize, Tetrahymena and Yeast to Human Cancer and Aging

Nature Medicine (2006)

Comprehensive review linking telomere biology to cancer pathogenesis and aging, synthesizing three decades of telomere research.

🏆Awards & Recognition 奖项与荣誉

🏆Nobel Prize in Physiology or Medicine (2009)
🏆Lasker Basic Medical Research Award (2006)
🏆Breakthrough Prize in Life Sciences (2006, Gairdner)
🏆Gairdner International Award (1998)
🏆American Cancer Society Medal of Honor (1998)
🏆L'Oréal-UNESCO Award for Women in Science (2008)

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 伊丽莎白·布莱克本 的研究动态

Follow Elizabeth H. Blackburn's research updates

留下邮箱,当我们发布与 Elizabeth H. Blackburn(University of California, San Francisco)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment